Price To Earnings Ratio 9.64 | Sector PE 65.09 |
PB Ratio 1.18 | Sector PB 8.49 |
EPS 10.46 | Dividend Yield 2.87 |
Today's Volume 727.364 K | 5 Day Avg. Volume 598.203 K |
PEG Ratio 0.24 | Market Cap. ₹ 2,670.00 Cr. |
Alembic Limited is an Indian company that develops, manufactures and markets pharmaceutical products such as dosage forms and active ingredients. The company operates through one segment, Pharmaceuticals. The Pharmaceutical segment manufactures and markets fermentation and chemical-based active ingredients (API). The company also conducts R&D in Vadodara. The company manufactures/provides three main products/services: Azithromycin, Venlafaxine and Telmisartan.